| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.09 |